Related Experiment Video
Updated: Jul 21, 2026
13:08
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
When to suspect hypercoagulability and how to investigate it.
1Department of Pathology, University of Alabama at Birmingham, AL 35233-7331, USA.
Annals of Diagnostic Pathology
|July 4, 2001
Summary
This review covers new genetic and acquired risk factors for venous thrombosis (blood clots). Understanding hypercoagulability is crucial for accurate diagnosis and patient care.
Area of Science:
- Hematology
- Thrombosis Research
Background:
- Venous thrombosis is a significant health concern.
- Recent years have seen a rise in identified genetic defects predisposing individuals to thrombosis.
- Increased availability of diagnostic assays for hypercoagulability has spurred discussion.
Purpose of the Study:
- To summarize current knowledge on novel risk factors for venous thrombosis.
- To highlight key aspects of hypercoagulability relevant for non-specialist pathologists.
- To guide pathologists in consulting other physicians on diagnosing hypercoagulability disorders.
Main Methods:
- Literature review of genetic and acquired causes of hypercoagulability.
- Synthesis of current understanding of thrombosis risk factors.
- Focus on diagnostic considerations for pathologists.
Main Results:
- An expanding list of genetic defects associated with increased thrombosis risk.
- Development and accessibility of new diagnostic assays for hypercoagulability.
- Identification of key issues for pathologists in managing hypercoagulability.
Conclusions:
- An informed approach to diagnosing hypercoagulability disorders is essential.
- Accurate diagnosis leads to more cost-effective and efficient patient care.
- Pathologists play a vital role in managing patients at risk for venous thrombosis.
More Related Videos
04:56Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
Published on: August 4, 2023
08:01The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...